Singapore’s sovereign wealth fund, GIC, has committed an additional US$150 million to Asia Healthcare Holdings (AHH), a healthcare platform specializing in single-specialty hospitals. This investment follows GIC’s initial US$170 million infusion in February 2022, underscoring its confidence in AHH’s growth trajectory.
AHH has strategically invested approximately US$300 million across various hospital chains, focusing on specialties such as oncology, mother and childcare, urology, nephrology, and fertility treatments. Notable entities under AHH’s umbrella include Motherhood Hospitals, Nova IVF, and the Asian Institute of Nephrology & Urology (AINU).
With this latest funding, GIC becomes the majority shareholder in AHH, valuing the company between US$800 million and US$900 million. TPG, the previous majority stakeholder, will transition to a minority position.
The fresh capital is expected to fuel AHH’s expansion into new specialties, including gastroenterology and diagnostics, further solidifying its position in South Asia’s healthcare sector.
GIC Invests Additional $150 Million in Asia Healthcare Holdings